Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1530171A discloses a robust heterogeneous catalyst system for producing high-ee hydroxy esters, enabling significant cost reduction in chiral synthesis manufacturing.
Advanced synthesis of 3-dehydroshikimic esters via IBX oxidation. A scalable, high-yield route for pharmaceutical intermediates offering significant cost and supply chain advantages.
Patent CN102558098A reveals a cost-effective one-pot synthesis for EGFR inhibitor intermediates, offering significant supply chain advantages for API manufacturers.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Novel one-pot method replaces Pd catalysis for EGFR inhibitor intermediates, offering cost-effective scale-up and high purity for pharma supply chains.
Patent CN1237040C reveals a high-yield synthesis method for ethylene glycol diaryl ether using neighboring group participation, offering significant cost and purity advantages for industrial supply chains.
Patent CN120271438A reveals a Pd-catalyzed method for aryl terminal alkyne. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN120004947A reveals green AlCl3 catalyzed route for phosphorus intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed route enables high-yield aryl terminal alkyne production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN103833691A reveals a novel acetylation route for producing cis/trans isomeric mixtures of this key fragrance and pharma intermediate with superior yield and purity.
Discover the patented efficient synthesis of pyrimidine furanone via Friedel-Crafts cyclization. Achieve high yields and reduced costs for pharmaceutical intermediates.
Patent CN104447540A offers copper-catalyzed amide synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN105254611A reveals a waste-utilization route for benzothiophene-2-carboxylic acid. This method offers significant supply chain stability and cost advantages.
Novel nickel-catalyzed method for high-purity thiochromone compounds. Reduces complexity and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN117326917B details a scalable four-step synthesis for high-purity hydroxytyrosol. This method offers significant cost reduction and supply chain reliability for industrial buyers.
Patent CN103122355A details a thermostable ketoreductase enabling high-purity chiral alcohol manufacturing with significant cost reduction and supply chain reliability.
Patent CN117165543A reveals a high-yield biocatalytic route for furfuryl alcohol. Discover cost-effective manufacturing and supply chain advantages for fine chemical intermediates.
Patent CN110028487A reveals nickel-catalyzed thiochromone synthesis offering high purity and scalable supply chain solutions for pharmaceutical intermediates manufacturing.